CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that it has entered into a data sharing agreement with Pfizer, a ...

The technology of Iterative Scopes technology is still in clinical testing, but Lilly sees enough promise to get an equity stake in the Cambridge, Massachusetts-based startup. The pharmaceutical giant ...

At a fork in the road, Aditya Khosla, Ph.D., is taking the path less traveled: one that will take him away from PathAI, the company he helped start half a decade ago. Khosla, who has also served as ...

Iterative Scopes Inc. picked up $30 million in series A financing to advance artificial intelligence (AI)-powered precision medicine for gastroenterology. The money will be used to further develop the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneering company aiming to bring cutting-edge precision medicine to gastroenterology, today disclosed that it has closed a $30 million Series A ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Iterative Scopes, the MIT spinout developing AI-powered ...

From a new chief medical officer to new FDA clearances, here are six Iterative Scopes updates Becker’s has reported on in 2022. 1. Iterative Scopes rebranded, changing its name to Iterative Health. 2.

The goal of the rebrand is to better reflect the company’s use of artificial intelligence to improve clinical research and decision making within gastroenterology, according to an Oct. 20 news release ...

After chipping in to its last two venture funding rounds, Johnson & Johnson is taking an even bigger chance on Iterative Scopes. The startup, which spun out of MIT in 2017, is developing artificial ...